ClinicalTrials.gg

Drug

Edotreotide yttrium y-90 clinical trials

Also written 90Y-DOTATOC.

studies test it
4
open now
0
in phase 3
0
first study started
2008

How studies write it

Studies that test it under each name

Other names

90Y-DOTATOC
2

Studies by the year they started

4 studies that test it; most in 2008 (1)

Studies that test edotreotide yttrium y-90, by start year
YearStudies
20081
20161
20171
20181

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 1 · Other 3

David Bushnell (1) · Sandeep Laroia (1) · Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (1) · Molecular Insight Pharmaceuticals, Inc. (1)

Often tested with

Tested in the same studies.

3-Iodobenzylguanidine (1)

Studies

Open first, then newest update. How each study uses edotreotide yttrium y-90 is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 1 — edotreotide yttrium y-90 is usual care beside what is tested

Codes

What other systems call edotreotide yttrium y-90 · ClinicalTrials.gg INT004742

  • UNII (FDA) ABF7OG3FA3EDOTREOTIDE YTTRIUM Y-90Confirmed FDA, NLM, Wikidata
  • Wikidata Q27273846edotreotide yttrium y-90Confirmed FDA, NLM, Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.